Lacidipine



Indications and Reactions:

Role Indications Reactions
Secondary
Overdose 50.0%
Product Used For Unknown Indication 15.0%
Hypertension 11.0%
Drug Use For Unknown Indication 6.0%
Diabetes Mellitus 4.0%
Agitated Depression 2.0%
Dyslipidaemia 2.0%
Prophylaxis Against Hiv Infection 2.0%
Rheumatoid Arthritis 2.0%
Vertigo 2.0%
Anxiety 1.0%
Depression 1.0%
Gastritis Prophylaxis 1.0%
Prophylaxis 1.0%
Shock 17.4%
Toxicity To Various Agents 13.0%
Hypoxia 8.7%
Transaminases Increased 8.7%
Aphasia 4.3%
Ataxia 4.3%
Atrioventricular Block Complete 4.3%
Cardiac Arrest 4.3%
Cholelithiasis 4.3%
Continuous Haemodiafiltration 4.3%
Drug-induced Liver Injury 4.3%
Hepatomegaly 4.3%
Hypotension 4.3%
Renal Failure Acute 4.3%
Respiratory Tract Infection 4.3%
Rhabdomyolysis 4.3%
Concomitant
Product Used For Unknown Indication 22.1%
Hypertension 18.1%
Drug Use For Unknown Indication 15.6%
Diffuse Large B-cell Lymphoma 7.5%
Diabetes Mellitus 5.3%
Atrial Fibrillation 4.2%
Prophylaxis 3.9%
Rheumatoid Arthritis 3.7%
Hepatic Neoplasm Malignant 2.0%
Renal Transplant 2.0%
Gastric Cancer 1.9%
Blood Pressure 1.7%
Cerebrovascular Accident Prophylaxis 1.6%
Nephrogenic Anaemia 1.6%
Pain 1.6%
Premedication 1.6%
Type 2 Diabetes Mellitus 1.6%
Blood Cholesterol Increased 1.4%
Osteoporosis 1.4%
Psoriasis 1.4%
Guillain-barre Syndrome 8.9%
Carotid Artery Stenosis 7.9%
Peripheral Arterial Occlusive Disease 7.9%
Tachycardia 7.9%
Hypotension 6.9%
Renal Failure 5.9%
Breast Cancer 5.0%
Renal Failure Acute 5.0%
Rhabdomyolysis 5.0%
Anaemia Haemolytic Autoimmune 4.0%
Device Malfunction 4.0%
Drug Interaction 4.0%
Haemoglobin Decreased 4.0%
Hypertension 4.0%
Malaise 4.0%
Osteonecrosis 4.0%
Death 3.0%
Dizziness 3.0%
Hepatocellular Damage 3.0%
Interstitial Lung Disease 3.0%
Interacting
Product Used For Unknown Indication 66.7%
Prophylaxis Against Hiv Infection 27.8%
Hiv Infection 2.8%
Hypertension 2.8%
Atrioventricular Block Complete 33.3%
Hypotension 33.3%
Atrioventricular Block 11.1%
Drug Interaction 11.1%
Tongue Oedema 11.1%